Kordasiewicz Holly B. 4/A

Accession 0000874015-26-000068

CIK 0000874015other

Filed

Jan 19, 7:00 PM ET

Accepted

Jan 20, 8:20 PM ET

Size

5.9 KB

Accession

0000874015-26-000068

Form 4/AAmended

Period: 2026-01-02

EVP, Chief Development Officer

Transactions

Award
Non-Qualified Stock Option (right to buy)
[F1]
2026-01-02+7,500→ 16,600 total
Exercise: $79.67From: 2027-01-02Exp: 2036-01-01→ Common Stock (7,500 underlying)

Footnotes (1)

[F1]Grant on 01/02/2026 to reporting person of stock options under the Ionis Pharmaceuticals, Inc. Amended and Restated 2011 Equity Incentive Plan. Following this transaction, the option was exercisable as to 0 shares on 01/02/2026. 25% of the shares subject to the option will vest and become exercisable on 01/02/2027. Thereafter, the remaining shares subject to the option will vest and become exercisable in 36 equal monthly installments over the next 3 years.

Signature

By: Patrick R. O'Neil, attorney-in-fact For: Holly Kordasiewicz|2026-01-20

Documents

1 file

IONIS PHARMACEUTICALS INC

CIK 0000874015

Entity typeother